J&J Joins Pharma Peers With $55B US Manufacturing Boost Following Trump’s Tariff threats In a move set to reshape the pharmaceutical landscape, Johnson & Johnson (J&J),...
Shilpa Medicare Secures SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets In a landmark development, Shilpa Medicare Ltd has received approval from the SEC-CDSCO for the production and...